| Beckman, Peter (Kiel (govt) 201204 Managing Director of KiWi GmbH + KiWi Tower GmbH) |
Managing Director |
|
Germany |
| Haass, Christian (Professor) |
Professor |
|
|
| Hombach, Michael (Univ Zürich 201106 Institute of Medical Microbiology) |
n. a. |
|
|
| Janositz, Paul |
journalism |
|
|
| Seidel, Wolfgang (Advigen 201201 before Innogenetics 2005–2009 VP BusDev + Bayer Pharma 1981–2004) |
Consultant (economic/technology) |
|
|
| Swanepoel, Lisa (Bruker 201008 Bruker South Africa + SAAMS) |
n. a. |
|
South Africa |
| Topp, Thomas (Cochlear 201009 Cochlear Deutschland GmbH & Co KG) |
n. a. |
|
|
| Weiss, Ludwig (SciXess GmbH 201105 Managing Director + CAST Tirol before HepaVec + MondoGen) |
n. a. |
|
|
| Wiech, Hans (Camoleon Knowledge Brokerage 201108) |
n. a. |
|
|
| Reineke, Ulrich (3B Pharmaceuticals 201010 Managing Director) |
Managing Director |
3B Pharmaceuticals GmbH |
Germany |
| Doppler, Clemens (3i Germany 2007 Director Healthcare Team) |
Investment Manager |
3i (Group) |
Germany |
| Friese, L. |
n. a. |
3i (Group) |
Germany |
| Burns, Robert F. (4-Antibody 201101– CEO before Affitech CEO before Celldex Therapeutics CEO) |
CEO (Chief Executive Officer) |
4-Antibody (Group) |
Switzerland |
| Grawunder, Ulf (4-Antibody 200810 CSO before CEO + founder) |
CSO (Chief Scientific Officer) |
4-Antibody (Group) |
Switzerland |
| Mason, Richard (4-Antibody 200809– CEO before Advent Venture Partners before Cambridge Antibody Technoogy SVP BusDev) |
CEO (Chief Executive Officer) |
4-Antibody (Group) |
Switzerland |
| Dauer, Ulrich (4SC Founder + since 2000 CEO STEPPED DOWN 3/13 before Tripos GmbH) |
CEO (Chief Executive Officer) |
4SC (Group) |
Germany |
| Gröppel, Manfred (4SC 200901 Business Development) |
Business Development Manager / Strategy Manager |
4SC (Group) |
Germany |
| Hentsch, Bernd (4SC 201009 Chief Development Officer) |
CSO (Chief Scientific Officer) |
4SC (Group) |
Germany |
| Keilhauer, Gerhard (4SC 200704) |
n. a. |
4SC (Group) |
Germany |
| Orlowski, Jochen (4SC 201206 Corporate Communications + Investor Relations) |
Public Relations Manager / Investor Relations Manager |
4SC (Group) |
Germany |
| Spillner, Enno (4SC 201304– CEO before CFO since 2005 before BioM Venture Capital GmbH Managing Director) |
CEO (Chief Executive Officer) |
4SC (Group) |
Germany |
| Vitt, Daniel (4SC 200607 CSO) |
CSO (Chief Scientific Officer) |
4SC (Group) |
Germany |
| von Klitzing, Bettina (4SC 200901 Manager Public Realtions & Investor Relations) |
Public Relations Manager / Investor Relations Manager |
4SC (Group) |
Germany |
| Backheuer, Axel (5 Prime GmbH 201105 Managing Director) |
Managing Director |
5 Prime (Group) |
Germany |
| Diehl, Hans-Josef (A&M Labor 201201 Managing Director of A & M STABTEST) |
Managing Director |
A&M Labor für Analytik (Group) |
Germany |
| Dill, Donald Nelson (A&M Labor 201201 Managing Director of A & M STABTEST) |
Managing Director |
A&M Labor für Analytik (Group) |
Germany |
| Martens, Lejon (A & M Labor für Analytik 201009 Head Mass Spec Lab) |
Head Mass Spectrometry Laboratory (industry) |
A&M Labor für Analytik (Group) |
Germany |
| Watt, Steven (Labor für Analytik 201009 Business Development A & M StabTest GmbH) |
Business Development Manager / Strategy Manager |
A&M Labor für Analytik (Group) |
Germany |
| Fischer, Hartmut (A&M Labor 201201 Managing Director) |
Managing Director |
A&M Labor für Analytik und Metabolismusforschung Service Gmb |
|
| Römer, Axel (A&M Labor 201201 Managing Director) |
Managing Director |
A&M Labor für Analytik und Metabolismusforschung Service Gmb |
|
| Stöhr, Thomas (A2M Pharma GmbH 201104 Managing Director) |
Managing Director |
A2M Pharma GmbH |
Germany |
| Enghild, Jan J. (Aarhus Univ 201106 Professor Laboratory for Proteome Analysis and Protein Characterisation) |
Professor |
Aarhus University |
Denmark |
| Merget, Oliver (ABB 201006 ABB Automation GmbH Sales Chemical Solutions) |
Sales Manager / Marketing Manager |
ABB (Group) |
Germany |
| Donnert, Gerald (Abberior GmbH 201110 Managing Director) |
Managing Director |
Abberior GmbH |
Germany |
| Friedman, Isaac (Abbott 201203 Head of STARLIMS business) |
President/Director/Head Business Group/Unit/Division |
Abbott (Group) |
Israel |
| Hasskarl, Horst |
n. a. |
Abbott (Group) |
Germany |
| Yu, Guo-Liang (Epitomics 201105 CEO) |
CEO (Chief Executive Officer) |
Abcam (Group) |
United States (USA) |
| Carvell, John (Aber Instruments 201302 Sales + Marketing Director) |
Sales Manager / Marketing Manager |
Aber Instruments Ltd. |
United Kingdom (GB) |
| Maurer, Karl-Heinz (ABF 201101– BusDev AB Enzymes GmbH before Henkel KGaA Corporate Director Biotechnology) |
Business Development Manager / Strategy Manager |
ABF (Group) |
Germany |
| Moelker, Adriaan (ABF 201105 Managing Director of AB Enzymes GmbH) |
Managing Director |
ABF (Group) |
Germany |
| Arth, Hans-Lothar (ABK Patent and Trademark Attorneys before Axxima) |
Patent Attorney |
ABK Patent, Trademark and Design Attorneys (Berlin) |
Germany |
| Stahlberg, Dirk (ACURIS Rechtsanwälte 200902) |
Patent Attorney |
ABK Patent, Trademark and Design Attorneys (Berlin) |
Germany |
| Monin, Jean-Fabien (AC Immune 200901– CFO before 14y at bioMérieux CFO Central Europe) |
CFO (Chief Financial Officer) |
AC Immune S.A. |
Switzerland |
| Hüttl, Reinhard F. (acatech 201002 + Member BioÖkonomieRat) |
Professor |
acatech – Deutsche Akademie der Technikwissenschaften |
Germany |
| Baumgartner, Tina (Accella Group 200806– Principal before Guava Technologies + SurroMed + GeneTrace Systems) |
Consultant (economic/technology) |
Accella Group |
United States (USA) |
| Schotters, Markus (Aceos GmbH 201104 Managing Director) |
Managing Director |
Aceos GmbH |
Germany |
| Drexler, Mathias (ACIB GmbH 201108 Managing Director) |
Managing Director |
ACIB GmbH – Austrian Centre of Industrial Biotechnology |
Austria |
| Glieder, Anton (ACIB GmbH 201108 Managing Director) |
Managing Director |
ACIB GmbH – Austrian Centre of Industrial Biotechnology |
Austria |
| Gerndt, Carsten (acphis 201011 Managing Director) |
Managing Director |
acphis GmbH & Co. KG |
Germany |
| Gerndt-Nijaka, Agnieszka (acphis 201011 Managing Director) |
Managing Director |
acphis GmbH & Co. KG |
Germany |
| Goundis, Dimitri (Acrongenomics 200709– CEO before Speedel before Medicines Co Inc before Roche) |
CEO (Chief Executive Officer) |
Acrongenomics Inc. |
United Kingdom (GB) |
| Tzouvalis, Plato (Acrongenomics 200704 President) |
n. a. |
Acrongenomics Inc. |
United Kingdom (GB) |
| Haehner, Thomas (Acrovis 201110 Managing Director) |
Managing Director |
Acrovis Biostructures GmbH |
Germany |
| Schmidt, Jochen (Altana 201301– R&D Analytics at Actega Terra GmbH before Abbott Products GmbH) |
Laboratory Manager (industry) |
Actega Terra GmbH |
Germany |
| Braunstein, Guy (Actelion 201108 Head Clinical Development) |
Clinical Research Manager |
Actelion (Group) |
Switzerland |
| Cawthorn, Robert (Actelion –201109 existent Chairman of Board Directors TO LEAVE BOARD in 2012) |
Board member, non-executive |
Actelion (Group) |
Switzerland |
| Clozel, Jean-Paul (Actelion 200607 CEO) |
CEO (Chief Executive Officer) |
Actelion (Group) |
Switzerland |
| Clozel, Martine (Actelion 201108 CSO) |
CSO (Chief Scientific Officer) |
Actelion (Group) |
Switzerland |
| Haefeli, Roland (Actelion 201105 VP Head Investor Relations + Public Affairs) |
Public Relations Manager / Investor Relations Manager |
Actelion (Group) |
Switzerland |
| Oakley, Andrew J. (Actelion 201106 CFO joined Actelion 2003) |
CFO (Chief Financial Officer) |
Actelion (Group) |
Switzerland |
| Schwarz, Otto (Actelion 201106– COO before Head Business Strategy + Operations since 2008) |
COO (Chief Operating Officer) |
Actelion (Group) |
Switzerland |
| Scodari, Joseph C. (Actelion –201107 Board Director RESIGNED 8/11) |
Board member, non-executive |
Actelion (Group) |
Switzerland |
| Tanaka, Satoshi (Actelion 201204 President of Actelion Japan + South Korea) |
President/Director/Head Business Group/Unit/Division |
Actelion (Group) |
Japan |
| Widmann, Thomas |
n. a. |
Actelion (Group) |
Switzerland |
| Pangratz, Christian (Activaero 201105– CBO before Nektar Therapeutics Director of Business Development) |
CBO (Chief Business Officer) |
Activaero (Group) |
Germany |
| Scheuch, Gerhard (Activaero 201105 CEO + Founder) |
CEO (Chief Executive Officer) |
Activaero (Group) |
Germany |
| Plümpe, Jörg (Active Motif Chromeon GmbH 200901) |
n. a. |
Active Motif (Group) |
Germany |
| Kemmann, Michael (Adapt Localization Services GmbH 201201 Managing Director) |
Managing Director |
Adapt Localization Services GmbH |
Germany |
| Chowrira, Bharatt (Addex 201108– CEO before Nektar Therapeutics COO before Merck & Co) |
CEO (Chief Executive Officer) |
Addex Therapeutics S.A. |
Switzerland |
| Dixon, Graham (Addex 201207– CSO + Head Research before Galapagos CSO + Entomed + F2G + AstraZeneca) |
CSO (Chief Scientific Officer) |
Addex Therapeutics S.A. |
Switzerland |
| Dyer, Tim (Addex CFO + Co-Founder LEFT 5/13) |
CFO (Chief Financial Officer) |
Addex Therapeutics S.A. |
Switzerland |
| Epping-Jordan, Mark (Addex Pharma –200806 CSO) |
CSO (Chief Scientific Officer) |
Addex Therapeutics S.A. |
Switzerland |
| Keywood, Charlotte (Addex Pharma 200812 CMO STEPPED DOWN 2013) |
CMO (Chief Medical Officer) |
Addex Therapeutics S.A. |
Switzerland |
| Maggos, Chris (Addex 201106–201302 Business Development + Communication STEPPED DOWN 2013) |
Business Development Manager / Strategy Manager |
Addex Therapeutics S.A. |
Switzerland |
| Massuyeau, Laurent (Addex 200804–200909 Head Business Developm before Idenix RESIGNED 9/09 at Addex) |
Business Development Manager / Strategy Manager |
Addex Therapeutics S.A. |
Switzerland |
| Mueller, André J. (Addex 201106 Chairman of the Board before Actelion CFO before Biogen before Sandoz) |
Board member, non-executive |
Addex Therapeutics S.A. |
Switzerland |
| Mutel, Vincent (Addex 2002c–201106 CEO stepped down 6/11) |
CEO (Chief Executive Officer) |
Addex Therapeutics S.A. |
Switzerland |
| Di Naro, Antonio Francesco (Adienne 201205 VEP + Founder) |
CEO (Chief Executive Officer) |
Adienne (Group) |
Italy |
| Kühner, Markus (Adolf Kühner AG 200905 CEO) |
CEO (Chief Executive Officer) |
Adolf Kühner AG |
Switzerland |
| Heß, Markus (Astra Diagnostics 201105 Managing Director) |
Managing Director |
ADT Altona Diagnostic Technologies GmbH (Altona Diagnostics) |
Germany |
| Kuhn, Hans (Altona Diagnostics 201203– before Norgenta) |
n. a. |
ADT Altona Diagnostic Technologies GmbH (Altona Diagnostics) |
Germany |
| Spengler, Ulrich (Astra Diagnostics 201105 Managing Director before Artus Managing Director) |
Managing Director |
ADT Altona Diagnostic Technologies GmbH (Altona Diagnostics) |
Germany |
| Ax, Oliver (ACD/Labs 200909– Account Manager Advanced Chemistry Development Germany GmbH) |
Sales Manager / Marketing Manager |
Advanced Chemistry Development (ACD/Labs) (Group) |
Germany |
| Brandau-Krug, Barbara (ACD/Labs 200909– Account Manager Advanced Chemistry Development Germany GmbH) |
Sales Manager / Marketing Manager |
Advanced Chemistry Development (ACD/Labs) (Group) |
Germany |
| Rheinwald, Gerd (ACD/Labs 201003 Application Specialist Advanced Chemistry Development Germany GmbH) |
n. a. |
Advanced Chemistry Development (ACD/Labs) (Group) |
Germany |
| Jeradi, Ahmad (Adanced Technology Company 201207 VP Strategy Business Dev elopment / M&A International Operations) |
Business Development Manager / Strategy Manager |
Advanced Technology Company K.S.C. (ATC) |
Kuwait |
| Spinner, Thomas L. (Advent International GmbH 2003) |
n. a. |
Advent International (Group) |
Germany |
| Mühlenbeck, Frank (aeris Capital 200912 Partner before First Ventury Equity) |
Partner (venture partner) |
Aeris Capital AG |
Switzerland |
| Hengstermann, Theo (Optimare 201004 CEO) |
CEO (Chief Executive Officer) |
Aerodata (Group) |
Germany |
| Rüssmeier, Nick (Optimare 201204 Mechanical Engineering) |
Engineer |
Aerodata (Group) |
Germany |
| Schultze, Ute (Optimare 201204 Sales Analytics) |
Sales Manager / Marketing Manager |
Aerodata (Group) |
Germany |
| Schulze, Rainer (Optimare 201211 Head Business Division Analytics) |
President/Director/Head Business Group/Unit/Division |
Aerodata (Group) |
Germany |
| Stahl, Hans J. (Aerodata 201303 CEO) |
CEO (Chief Executive Officer) |
Aerodata (Group) |
Germany |
| Wieser, Jochen (Optimare 201003 Dept of Science) |
Researcher (industry) |
Aerodata (Group) |
Germany |
| Busse, Wolf-Dieter (Aerovance 200408– CEO before Bayer SVP Biotech) |
CEO (Chief Executive Officer) |
Aerovance Inc. |
United States (USA) |
| Döring, Martina (aevotis 201011 Managing Director) |
Managing Director |
aevotis GmbH |
Germany |
| Landschütze, Volker (aevotis 201011 Managing Director) |
Managing Director |
aevotis GmbH |
Germany |
| Bös, Michael (Affectis 200610– VP RnD before Boehringer Ingelheim Canada) |
Research & Development Manager |
Affectis Pharmaceuticals AG |
Germany |
| Martin, Alex (Affectis 201003–CEO before CFO before Intercept before BioXell 200606 CFO before Novartis) |
CEO (Chief Executive Officer) |
Affectis Pharmaceuticals AG |
Germany |
| Murray, Stephen (Affectis 201105– CMO befrore Memory Pharmaceuticals before Pfizer Pharmaceuticals) |
CMO (Chief Medical Officer) |
Affectis Pharmaceuticals AG |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2011.jpg){kind=logo}
![Banner [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
